GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OraSure Technologies Inc (FRA:EP3) » Definitions » Cyclically Adjusted PS Ratio

OraSure Technologies (FRA:EP3) Cyclically Adjusted PS Ratio : 1.25 (As of Jun. 23, 2024)


View and export this data going back to . Start your Free Trial

What is OraSure Technologies Cyclically Adjusted PS Ratio?

As of today (2024-06-23), OraSure Technologies's current share price is €4.20. OraSure Technologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €3.35. OraSure Technologies's Cyclically Adjusted PS Ratio for today is 1.25.

The historical rank and industry rank for OraSure Technologies's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:EP3' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.93   Med: 3.85   Max: 11.54
Current: 1.21

During the past years, OraSure Technologies's highest Cyclically Adjusted PS Ratio was 11.54. The lowest was 0.93. And the median was 3.85.

FRA:EP3's Cyclically Adjusted PS Ratio is ranked better than
66.18% of 479 companies
in the Medical Devices & Instruments industry
Industry Median: 2.12 vs FRA:EP3: 1.21

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

OraSure Technologies's adjusted revenue per share data for the three months ended in Mar. 2024 was €0.673. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €3.35 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


OraSure Technologies Cyclically Adjusted PS Ratio Historical Data

The historical data trend for OraSure Technologies's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OraSure Technologies Cyclically Adjusted PS Ratio Chart

OraSure Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.51 4.46 3.27 1.53 2.30

OraSure Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.80 1.45 1.67 2.30 1.68

Competitive Comparison of OraSure Technologies's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, OraSure Technologies's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OraSure Technologies's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OraSure Technologies's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where OraSure Technologies's Cyclically Adjusted PS Ratio falls into.



OraSure Technologies Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

OraSure Technologies's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=4.20/3.35
=1.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OraSure Technologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, OraSure Technologies's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.673/131.7762*131.7762
=0.673

Current CPI (Mar. 2024) = 131.7762.

OraSure Technologies Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.339 100.560 0.444
201409 0.381 100.428 0.500
201412 0.415 99.070 0.552
201503 0.438 99.621 0.579
201506 0.478 100.684 0.626
201509 0.469 100.392 0.616
201512 0.524 99.792 0.692
201603 0.466 100.470 0.611
201606 0.497 101.688 0.644
201609 0.508 101.861 0.657
201612 0.588 101.863 0.761
201703 0.518 102.862 0.664
201706 0.589 103.349 0.751
201709 0.571 104.136 0.723
201712 0.705 104.011 0.893
201803 0.559 105.290 0.700
201806 0.600 106.317 0.744
201809 0.628 106.507 0.777
201812 0.707 105.998 0.879
201903 0.433 107.251 0.532
201906 0.553 108.070 0.674
201909 0.526 108.329 0.640
201912 0.719 108.420 0.874
202003 0.462 108.902 0.559
202006 0.401 108.767 0.486
202009 0.561 109.815 0.673
202012 0.720 109.897 0.863
202103 0.676 111.754 0.797
202106 0.664 114.631 0.763
202109 0.636 115.734 0.724
202112 0.781 117.630 0.875
202203 0.852 121.301 0.926
202206 1.047 125.017 1.104
202209 1.616 125.227 1.701
202212 1.599 125.222 1.683
202303 1.957 127.348 2.025
202306 1.076 128.729 1.101
202309 1.124 129.860 1.141
202312 0.928 129.419 0.945
202403 0.673 131.776 0.673

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


OraSure Technologies  (FRA:EP3) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


OraSure Technologies Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of OraSure Technologies's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


OraSure Technologies (FRA:EP3) Business Description

Traded in Other Exchanges
Address
220 East First Street, Bethlehem, PA, USA, 18015
OraSure Technologies is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets most of its sales from the molecular solutions business, derived mainly from customers in the United States.

OraSure Technologies (FRA:EP3) Headlines

No Headlines